Series date: 
01/09/2024 - 12:00pm CST to 12/31/2024 - 1:00pm CST

Location

Zoom Virtual Conference Room


Frequency

Monthly- first Tuesday


Series Director

Zeenat Safdar, MD, MS

Lisa Kopas, MD


Overview

There is a need for physicians, residents, and fellows to continually update their knowledge in the treatment of patients with interstitial lung disease (ILD). A join statement from the American Thoracic Association (ATS) and European Respiratory Society (ERS) on the classification of idiopathic interstitial pneumonia (IIP) recommended an integrated approach to the diagnosis of ILD, involving clinicians, radiologists and, when lung biopsy has been performed, pathologists. This recommendation was reinforced in the updated guidelines in 2013 and 2015 by ATS/ERS. Educational methods will include lecture, case presentations, and question & answer session. 


Target Audience and Needs

The target audience for this activity is: physicians, pulmonologists, radiologists, pathologists, rheumatologists, general surgeons, residents, pulmonary-critical care fellows, nurses, physician's assistants, and medical students. 


Accreditation/Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Houston Methodist designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Series location: 
Dunn Rio Grande
TX
United States

Sessions